Alessandra Bandera
Overview
Explore the profile of Alessandra Bandera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
235
Citations
4151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bolis M, Uceda Renteria S, Alagna L, Liparoti A, Passerini B, Pastena A, et al.
BMC Infect Dis
. 2025 Mar;
25(1):359.
PMID: 40082784
Background: Prolonged SARS-CoV-2 infection observed in immunocompromised individuals even in the presence of antiviral treatment provides opportunities for viruses to evolve in immune escape and drug-resistant variants. Case Presentation: A...
2.
Taramasso L, Rossotti R, Tavelli A, Santoro M, Mazzotta V, Bandera A, et al.
J Acquir Immune Defic Syndr
. 2025 Feb;
98(4):352-356.
PMID: 39970315
Background: The best therapeutic management for people with HIV (PWH) who have a history of preexposure prophylaxis (PrEP) is still debated. Objectives: The aim of this study was to describe...
3.
Lombardi A, Renisi G, Liparoti A, Bobbio C, Bandera A
Transpl Infect Dis
. 2025 Jan;
:e14448.
PMID: 39888105
Background: Infections are a common complication among lung transplant recipients (LuTR), particularly in the first year post-transplant, with respiratory tract infections (RTI) being predominant. Syndromic molecular panels have been suggested...
4.
Colaneri M, Canuti M, Torrigiani G, DallOlio L, Bobbio C, Baldi S, et al.
Infect Dis Ther
. 2025 Jan;
14(2):447-461.
PMID: 39838255
Introduction: Predictors of coronavirus disease 2019 (COVID-19)-related rehospitalization remain underexplored. This study aims to identify the main risk factors associated with rehospitalizations due to severe acute respiratory syndrome coronavirus 2...
5.
Lombardi A, Grossi P, Mikulska M, Giannella M, Pascale R, Marinello S, et al.
Transpl Infect Dis
. 2025 Jan;
e14413.
PMID: 39791921
Introduction: Infections significantly impact morbidity and mortality in lung transplant (LuTx) recipients. This survey focused on documenting current practices regarding the prevention and management of infections in LuTx in Italy....
6.
Lombardi A, Mangioni D, Renisi G, Fumagalli J, Morlacchi L, Rosso L, et al.
Transplant Proc
. 2025 Jan;
57(2):339-341.
PMID: 39788793
Infectious complications significantly impact morbidity and mortality following lung transplantation (LuTx), with over 25% of post-transplant deaths attributed to infections. Antibiotic prophylaxis during the surgical procedure is crucial for reducing...
7.
Comelli A, Genovese C, Renisi G, Scudeller L, Zanforlini M, Macaluso G, et al.
Infect Prev Pract
. 2024 Dec;
6(4):100416.
PMID: 39691840
A Delphi consensus-seeking procedure was conducted to validate a list of ICD-9-CM codes that could help identify hospital admissions in which antimicrobials are more likely to be prescribed. The panel...
8.
Ceraolo M, Leccese M, Cassotta A, Triolo S, Bombaci M, Coluccio E, et al.
Eur J Immunol
. 2024 Dec;
55(2):e202451404.
PMID: 39663678
Identifying activated T lymphocytes and differentiating antigen-specific from bystander T cells is crucial for understanding adaptive immune responses. This study investigates the efficacy of activation-induced markers (AIMs) in distinguishing these...
9.
Alteri C, Teri A, Liporace M, Muscatello A, Terranova L, Schianca M, et al.
Ann Clin Microbiol Antimicrob
. 2024 Nov;
23(1):104.
PMID: 39614286
Background: During prolonged FDC therapy, the emergence of FDC non-susceptibility in CRAB has been reported. Here, we report a transmission cluster of FDC-non-susceptible CRAB in four patients, all naïve to...
10.
Bozzi G, Centazzo M, Scaglioni S, Butta G, Saltini P, Liparoti A, et al.
AIDS
. 2024 Oct;
38(10):1601-1604.
PMID: 39422635
No abstract available.